WCG
CLB icon

Weaver Consulting Group’s Core Laboratories CLB Stock Holding History

Weaver Consulting Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4
Closed – – 272
2020
Q3 		$0 Hold
4
– – ﹤0.01% 965
2020
Q2 		$0 Hold
4
– – ﹤0.01% 942
2020
Q1 		$0 Hold
4
– – ﹤0.01% 859
2019
Q4 		$0 Hold
4
– – ﹤0.01% 842
2019
Q3 		$0 Hold
4
– – ﹤0.01% 826
2019
Q2 		$0 Buy
+4
New +$235 ﹤0.01% 818

Other funds holding CLB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Weaver Consulting Group's CLB Position: Q4 2020 in Review

Weaver Consulting Group sold out of Core Laboratories (CLB) in Q4 2020, closing a stake of 4 shares.

Weaver Consulting Group first reported a position in CLB in Q2 2019 and held it in 6 quarters. The position peaked at $0 in Q3 2020. 181 funds tracked by Wall St. Rank hold CLB as of Q4 2020.

  • Weaver Consulting Group reported no remaining Core Laboratories position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 4 Core Laboratories shares in Q4 2020.
  • Weaver Consulting Group first reported a position in Core Laboratories in Q2 2019 and held it in 6 quarters.
  • Weaver Consulting Group's Core Laboratories position peaked at $0 in Q3 2020.
  • 181 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.